Abstract:1. CNBP is associated with poor prognosis and clinical progression of neuroblastoma. 2. KPNB1 facilitates nuclear translocation of CNBP to interact with SMARCC2 in liquid condensates. 3. CNBP modulates SWI/SNF activity via SMARCC2 to drive ribosome biogenesis of neuroblastoma cells and subsequent M2 macrophage polarisation. 4. Therapeutic targeting of phase separation and interaction of CNBP with SMARCC2 inhibits neuroblastoma progression. Background Neuroblastoma (NB) is the most common extracranial malignancy in childhood; however, the mechanisms underlying its aggressive characteristics still remain elusive. Methods Integrative data analysis was performed to reveal tumour‐driving transcriptional regulators. Co‐immunoprecipitation and mass spectrometry assays were applied for protein interaction studies. Real‐time reverse transcription‐polymerase chain reaction, western blotting, sequential chromatin immunoprecipitation and dual‐luciferase reporter assays were carried out to explore gene expression regulation. The biological characteristics of NB cell lines were examined via gain‐ and loss‐of‐function assays. For survival analysis, the Cox regression model and log‐rank tests were used. Results Cellular nucleic acid‐binding protein (CNBP) was found to be an independent factor affecting NB outcome, which exerted oncogenic roles in ribosome biogenesis, tumourigenesis and aggressiveness. Mechanistically, karyopherin subunit beta 1 (KPNB1) was responsible for nuclear transport of CNBP, whereas liquid condensates of CNBP repressed the activity of switch/sucrose‐nonfermentable (SWI/SNF) core subunits (SMARCC2/SMARCC1/SMARCA4) via interaction with SMARCC2, leading to alternatively increased activity of SMARCC1/SMARCA4 binary complex in facilitating gene expression essential for 18S ribosomal RNA (rRNA) processing in tumour cells, extracellular vesicle‐mediated delivery of 18S rRNA and subsequent M2 macrophage polarisation. A cell‐penetrating peptide blocking phase separation and interaction of CNBP with SMARCC2 inhibited ribosome biogenesis and NB progression. High KPNB1, CNBP, SMARCC1 or SMARCA4 expression or low SMARCC2 levels were associated with poor survival of NB patients. Conclusions These findings suggest that CNBP phase separation is a target for inhibiting ribosome biogenesis and tumour progression in NB via modulating SWI/SNF complex activity.

Krüppel‐like Factor 9 Promotes Neuroblastoma Differentiation Via Targeting the Sonic Hedgehog Signaling Pathway

Smoothened-Independent Activation of Hedgehog Signaling by Rearranged During Transfection Promotes Neuroblastoma Cell Proliferation and Tumor Growth

KLF7 promotes neuroblastoma differentiation through the GTPase signaling pathway by upregulating neuroblast differentiation-associated protein AHNAKs and glycerophosphodiesterase GDPD5

CRISPR-Cas9 Screening Develops an Epigenetic and Transcriptional Gene Signature for Risk Stratification and Target Prediction in Neuroblastoma

Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity

LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1

Lncrna SNHG16 is Associated with Proliferation and Poor Prognosis of Pediatric Neuroblastoma.

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications

Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1

Polo-like Kinase 4 Mediates Epithelial–mesenchymal Transition in Neuroblastoma Via PI3K/Akt Signaling Pathway

Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo

Foxd3 is A Novel Tumor Suppressor That Affects Growth, Invasion, Metastasis and Angiogenesis of Neuroblastoma

LncRNA HCP5 Promotes Neuroblastoma Proliferation by Regulating Mir-186-5p/map3k2 Signal Axis.

Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma

HIF-1α Contributes to Proliferation and Invasiveness of Neuroblastoma Cells Via SHH Signaling.

PHF20 Collaborates with PARP1 to Promote Stemness and Aggressiveness of Neuroblastoma Cells Through Activation of SOX2 and OCT4

Downregulation of Bone Morphogenetic Protein Receptor 2 Promotes the Development of Neuroblastoma

LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma

Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma

Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation

Expression of Krüppel-like Factor 9 in Breast Cancer Patients and Its Effect on Prognosis.